Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2Phase 3 Interventional Accepts healthy volunteers Results available

Efficacy and Safety of Clesrovimab (MK-1654) in Infants (MK-1654-004)

ClinicalTrials.gov ID: NCT04767373

Public ClinicalTrials.gov record NCT04767373. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 11:13 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2b/3 Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of MK-1654 in Healthy Pre-Term and Full-Term Infants

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary objectives of this phase 2b/3 double-blind, randomized, placebo-controlled study are to evaluate the efficacy and safety of clesrovimab in healthy pre-term and full-term infants. It is hypothesized that clesrovimab will reduce the incidence of respiratory syncytial virus (RSV)-associated medically attended lower respiratory infection (MALRI) from Days 1 through 150 postdose compared to placebo.

Study identification

NCT ID
NCT04767373
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2, Phase 3
Lead sponsor
Merck Sharp & Dohme LLC
Industry
Enrollment
3,632 participants

Conditions and interventions

Interventions

Biological · Drug

Eligibility (public fields only)

Age range
Up to 1 Year
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 7, 2021 (Actual)
Primary completion
Jul 9, 2024 (Actual)
Completion
Jul 9, 2024 (Actual)
Last update posted
Feb 11, 2026

2021 – 2024

United States locations

U.S. sites
51
U.S. states
24
U.S. cities
48
Facility City State ZIP Site status
Southeastern Pediatric Associates, P.A. ( Site 0008) Dothan Alabama 36303 —
Northwest Arkansas Pediatric Clinic ( Site 0050) Fayetteville Arkansas 72703 —
Children's Clinic of Jonesboro, PA ( Site 0058) Jonesboro Arkansas 72401 —
Long Beach Memorial Medical Center ( Site 0014) Long Beach California 90806 —
Madera Family Medical Group ( Site 0046) Madera California 93637 —
Orange County Research Institute ( Site 0057) Ontario California 91762 —
Children's Hospital Colorado ( Site 0066) Aurora Colorado 80045 —
Optumcare Colorado Springs, LLC ( Site 0022) Colorado Springs Colorado 80922 —
Children's National Hospital ( Site 0076) Washington D.C. District of Columbia 20010 —
MedStar Georgetown Pediatrics ( Site 0047) Washington D.C. District of Columbia 20016 —
Next Phase Research Alliance, LLC ( Site 0071) Homestead Florida 33030 —
Acevedo Clinical Research Associates ( Site 0002) Miami Florida 33142 —
Tekton Research ( Site 0080) Chamblee Georgia 30341 —
Meridian Clinical Research, LLC ( Site 0083) Macon Georgia 31210 —
Clinical Research Prime ( Site 0075) Idaho Falls Idaho 83404 —
Saltzer Medical Group ( Site 0004) Nampa Idaho 83686 —
Cotton-O'Neil Clinical Research Center PediatricCare ( Site 0061) Topeka Kansas 66604 —
ACC Pediatric Research ( Site 0067) Haughton Louisiana 71037 —
Meridian Clinical Research, LLC ( Site 0082) Hastings Nebraska 68901 —
Midwest Children's Health Research Institute, LLC ( Site 0044) Lincoln Nebraska 68504 —
Dartmouth-Hitchcock Medical Center ( Site 0031) Lebanon New Hampshire 03756 —
Rutgers University-Pediatric Clinical Research Center ( Site 0055) New Brunswick New Jersey 08901 —
Javara - Wake Forest Health Network - Ford, Simpson, Lively & Rice Pediatrics ( Site 0093) Winston-Salem North Carolina 27103 —
Senders Pediatrics ( Site 0062) Cleveland Ohio 44121 —
Ohio Pediatric Research Association ( Site 0063) Dayton Ohio 45414 —
CCP- Kid's Way ( Site 0017) Hermitage Pennsylvania 16148 —
UPMC Children's Hospital of Pittsburgh - Primary Care Center - Oakland ( Site 0043) Pittsburgh Pennsylvania 15213 —
Coastal Pediatric Research ( Site 0013) Charleston South Carolina 29414 —
Tribe Clinical Research, LLC ( Site 0015) Greenville South Carolina 29607 —
Holston Medical Group ( Site 0040) Kingsport Tennessee 37660 —
Javara - Privia Medical Group North Texas - Frisco ( Site 0086) Frisco Texas 75035 —
University of Texas Medical Branch at Galveston ( Site 0059) Galveston Texas 77555 —
DM Clinical Research ( Site 0005) Houston Texas 77065 —
FMC Science - Lampasas ( Site 0011) Lampasas Texas 76550 —
DCOL Center for Clinical Research ( Site 0042) Longview Texas 75605 —
University Health System- San Antonio ( Site 0048) San Antonio Texas 78229 —
Private Practice - Dr. Etokhana ( Site 0089) San Antonio Texas 78244 —
Road Runner Research, Ltd ( Site 0049) San Antonio Texas 78249 —
Alliance for Multispecialty Research, LLC ( Site 0092) Kaysville Utah 84037 —
Wee Care Pediatrics ( Site 0077) Layton Utah 84041 —
Cottonwood Pediatrics ( Site 0032) Murray Utah 84107 —
Wee Care Pediatrics-Roy ( Site 0053) Roy Utah 84067 —
University of Utah School of Medicine ( Site 0006) Salt Lake City Utah 84108 —
Copperview Medical Center ( Site 0078) South Jordan Utah 84095 —
Wee Care Pediatrics ( Site 0065) Syracuse Utah 84075 —
Pediatric Research of Charlottesville, LLC ( Site 0073) Charlottesville Virginia 22902 —
MultiCare Rockwood Cheney Clinic ( Site 0068) Cheney Washington 99004 —
Multicare Health System Institute for Research and Innovation ( Site 0025) Spokane Washington 99202 —
Multicare Institute For Research And Innovation ( Site 0045) Tacoma Washington 98405 —
Marshall University School of Medicine and Medical Center ( Site 0064) Huntington West Virginia 25701 —
Marshfield Clinic ( Site 0054) Marshfield Wisconsin 54449 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 166 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04767373, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 11, 2026 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04767373 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →